2025年2月24日，安徽山河药用辅料股份有限公司（证券简称：山河药辅，证券代码：300452）发布了关于5%以上股东减持股份计划的预披露公告。公告显示，公司主要股东上海复星医药产业发展有限公司（以下简称“复星医药”）因经营需要，计划在未来一段时间内减持其所持有的公司股份。根据公告，复星医药目前持有山河药辅股份23,928,059股，占公司总股本的10.20%。此次减持计划涉及不超过6,978,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.